Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk

por Lokhande, Lavanya, Kuci Emruli, Venera, Kolstad, Arne, Hutchings, Martin, Räty, Riikka, Jerkeman, Mats, Ek, Sara
Publicado 2020

Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma

por Lokhande, Lavanya, Kuci Emruli, Venera, Eskelund, Christian Winther, Kolstad, Arne, Hutchings, Martin, Räty, Riikka, Niemann, Carsten Utoft, Grønbæk, Kirsten, Jerkeman, Mats, Ek, Sara
Publicado 2021

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma

por Nikkarinen, Anna, Lokhande, Lavanya, Amini, Rose-Marie, Jerkeman, Mats, Porwit, Anna, Molin, Daniel, Enblad, Gunilla, Kolstad, Arne, Räty, Riikka, Hutchings, Martin, Weibull, Caroline E., Hollander, Peter, Ek, Sara, Glimelius, Ingrid
Publicado 2023